A Phase Ⅱ Study of Gemcitabine Combination With TS-1 in Patient With Advanced or Recurred Pancreatic Cancer

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
The primary objective of the study is to Evaluate the response rate of Gemcitabine with TS-1 in Korean patient with advanced but inoperable, metastatic or recurrent pancreatic cancer who is not receiving anti cancer therapy.
Epistemonikos ID: 4f79e4a5d8e834dfee330bfa45e43c7748bf82f5
First added on: May 04, 2024